Read about how nurses have reacted to the launch of a targeted vaccination programme against gonorrhoea across all four UK ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

FGN has awarded a patent through special license to the UNIJOS for the institution’s groundbreaking invention of an Anti-Tick ...

World Health Organization and partners have been derailed by mismanagement and blind allegiance to an outdated strategy.

The CDC says vaccination rates for kindergartners across the U.S. now averages 92.1%, down from roughly 93% in 2024.

One particular S&P 500 biotech continues to stink out our writer's Stocks and Shares ISA. Is it time he chucked in the towel? The post This S&P 500 stock could surge 55% in just 12 months, according ...

Australia saw a record number of RSV cases last year, and NHS officials have suggested that the Australian winter often ...

In a retrospective analysis of patients who received peptide vaccines via n-of-1 programs, 89 percent had immune reactions.